Table 4 Phenotypic and genotypic characteristics of 25 pneumococcal strains isolated from children with AOM
No of strain | Serotype | Antibiotic resistance pattern | Site of isolation | Sequence type | Predicted founder ST/CCa | Related PMEN clone | ||
|---|---|---|---|---|---|---|---|---|
AOM | PT visit | |||||||
MEF R/L | NP/OP | NP/OP | ||||||
1 | 14 | PECcSxt | +/+ | +/− | +/− | 143 | 156/CC1 | Spain 9 V-3 DLV |
2 | 19F | PTeCSxt | −/+ | +/− | −/− | 423 | 15/CC3 | England 14–9 SLV |
3 | 14 | PECcTeSxt | +/− | +/− | NA | 156 | 156/CC1 | Spain 9 V-3 |
5 | 14 | PECcTeSxt | +/− | +/− | +/+ | 156 | 156/CC1 | Spain 9 V-3 |
10 | 19F | PECcTeCSxt | −/+ | +/+ | −/− | 87 | 88/CC50 | |
11 | 23F | PECcTeCSxt | +/+ | +/− | +/+ | 2033 | 81/CC13 | Spain 23F-1 SLV |
14 | 19F | PECcTeCSxt | +/− | −/− | −/− | 87 | 88/CC50 | |
22 | 22F | S | −/− | −/+ | −/− | 433 | 433/CC23 | |
27 | 18C | S | −/+ | −/− | −/− | 496 | 496/CC192 | |
28 | 23F | PECcTeSxt | +/+ | +/+ | +/− | 81 | 81/CC13 | Spain 23F-1 |
30 | 6B | PECcCSxt | +/+ | −/− | −/− | 135 | 473/CC8 | |
31 | 14 | PECcSxt | +/+ | −/− | −/− | 143 | 156/CC1 | |
33 | 19A | PECcTeSxt | −/− | +/− | −/+ | 320 | 320CC2 | |
35A | 19F | PECcSxt | −/+ | −/− | +/− | 320 | 320/CC2 | |
35B | 19F | PECcSxt | −/− | +/− | −/− | 9062 | 320/CC2 | |
41 | 14 | E | +/− | +/− | −/− | 9 | 15/CC3 | England 14–9 |
42 | 15A | PECcTe | −/− | −/+ | +/− | 374 | 63/CC10 | Sweden 15A-25 SLV |
44 | 14 | PECcTe | −/+ | +/− | +/− | 10,340 | 156/CC1 | |
48A | 14 | PECcSxt | −/− | −/− | +/− | 10,342 | 88/CC50 | |
48B | 14 | PECcTeCSxt | −/− | −/− | +/− | 15 | 15/CC3 | England 14–9 SLV |
49 | 14 | PECcTeSxt | −/− | +/− | +/− | 156 | 156/CC1 | Spain 9 V-3 |
55 | 14 | PECcSxt | −/+ | +/− | +/− | 15 | 15/CC3 | England 14–9 SLV |
56 | 6B | PECcTeCSxt | −/− | +/− | −/− | 135 | 473/CC8 | |
60 | 3 | S | +/+ | +/− | −/− | 505 | 180/CC16 | |
62 | 19F | TeCSxt | +/+ | −/− | −/− | 423 | 15/CC3 | England 14–9 SLV |